Oncolytic virus DNX-2401 with a short course of temozolomide for glioblastoma at first recurrence: Clinical data and prognostic biomarkers

被引：18
|
作者：
Alonso, Marta M.
Garcia-Moure, Marc
Gonzalez-Huarriz, Marisol
Marigil, Miguel
Hernandez-Alcoceba, Ruben
Bunales, Maria
Hervas, Sandra
Gallego, Jaime
Gomez-Manzano, Candelaria
Fueyo, Juan
Lang, Frederick
Peterkin, Joanna
Diez-Valle, Ricardo
Tejada, Sonia
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-CT027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT027
引用
收藏
页数：2
相关论文
共 9 条
  • [1] A PHASE I STUDY OF THE ONCOLYTIC VIRUS DNX-2401 AND A SHORT COURSE TEMOZOLOMIDE FOR GLIOBLASTOMA AT FIRST RECURRENCE
    Tejada, Sonia
    Diez Valle, Ricardo
    Gallego, Jaime
    Alonso, Marta M.
    Peterkin, Joana
    NEURO-ONCOLOGY, 2016, 18 : 4 - 4
  • [2] ONCOLYTIC VIRUS FOR DIPG: THE CLINICAL EXPERIENCE WITH DNX-2401
    Alonso, Marta M.
    Inigo-Marco, Ignacio
    Garcia-Moure, Marc
    Gonzalez-Huarriz, Marisol
    Jones, Chris
    Mackay, Alan
    Hulleman, Esther
    Van der Lugt, Jasper
    De Andrea, Carlos
    Villalba, Maria
    Hernandez, Ruben
    Hervas, Sandra
    Tamayo, Ibon
    Lang, Frederick
    Gomez-Manzano, Candelaria
    Fueyo, Juan
    Diez-Valle, Ricardo
    Gallego-perez de larraya, Jaime
    Tejada, Sonia
    NEURO-ONCOLOGY, 2020, 22 : 38 - 38
  • [3] PHASE I TRIAL OF DNX-2401 ONCOLYTIC ADENOVIRUS COMBINED WITH A SHORT COURSE OF DOSE-DENSE TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA
    Perez-Larraya, J. Gallego
    Garcia-Moure, M.
    Gonzalez-Huarriz, M.
    Zalacain, M.
    Marrodan, L.
    Puigdelloses, M.
    Labiano, S.
    de la Nava, D.
    Laspidea, V.
    Ausejo, I.
    Hervas, I.
    Esparragosa, I.
    Giraldez, M.
    Dominguez, P.
    Martinez-Simon, A.
    Idoate, M.
    Fueyo, J.
    Gomez-Manzano, C.
    Patino, A.
    Diez-Valle, R.
    Tejada, S.
    Alonso, M.
    NEURO-ONCOLOGY, 2023, 25 : 120 - 120
  • [4] PHASE I CLINICAL TRIAL WITH ONCOLYTIC VIRUS DNX-2401 FOR DIPGS
    Inigo-Marco, Ignacio
    Diez-Valle, Ricardo
    Garcia-Moure, Marc
    Patino-Garcia, Ana
    Gonzalez Huarriz, Marisol
    Jones, Chris
    Gomez-Manzano, Candelaria
    Fueyo, Juan
    Alonso, Marta M.
    Tejada, Sonia
    NEURO-ONCOLOGY, 2019, 21 : 283 - 284
  • [5] PHASE I CLINICAL TRIAL WITH ONCOLYTIC VIRUS DNX-2401 FOR DIPGS
    Alonso, M. M.
    Inigo, I.
    Gonzalez-Huarriz, M.
    Dominguez, P.
    Patino, A.
    Jones, C.
    Gomez-Manzano, C.
    Fueyo, J.
    Diez-Valle, R.
    Tejada, S.
    NEURO-ONCOLOGY, 2019, 21 : 11 - 11
  • [6] IMMUNOMARKERS IN THE DNX-2401 (DELTA-24-RGD) ONCOLYTIC VIRUS PHASE I CLINICAL TRIAL
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Villalobos, Paloma
    Rodriguez-Canales, Jaime
    Wistuba, Ignacio
    Hess, Kenneth R.
    Alonso, Marta M.
    Tejada, Sonia
    Valle, Ricardo Diez
    Ewald, Brett
    Tufaro, Frank
    Lang, Fred
    NEURO-ONCOLOGY, 2017, 19 : 27 - 27
  • [7] PHASE 1B OPEN-LABEL RANDOMIZED STUDY OF THE ONCOLYTIC VIRUS DNX-2401 ADMINISTERED WITH OR WITHOUT INTERFERON GAMMA FOR RECURRENT GLIOBLASTOMA
    Tufaro, Frank
    Peterkin, Joanna
    Gammon, Karen
    Salvosa, Marita
    Mitchell, Erin
    Ewald, Brett
    Tonkin, Michele
    Rao, Pallavi
    Rowland, Kari Anne
    Chan, Winnie
    Forsythe, Sheri
    NEURO-ONCOLOGY, 2016, 18 : 24 - 24
  • [8] PHASE I CLINICAL TRIAL OF ONCOLYTIC VIRUS DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO-IMMUNOTHERAPY
    Lang, Frederick F.
    Conrad, Charles
    Gomez-Manzano, Cande
    Tufaro, Frank
    Sawaya, Raymond
    Weinberg, Jeffrey
    Prabhu, Sujit
    Fuller, Gregory
    Aldape, Kenneth
    Fueyo, Juan
    NEURO-ONCOLOGY, 2014, 16
  • [9] FIRST-IN-HUMAN PHASE I CLINICAL TRIAL OF ONCOLYTIC DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO-IMMUNOTHERAPY
    Lang, Frederick F.
    Conrad, Charles
    Gomez-Manzano, Cande
    Tufaro, Frank
    Yung, W. K. A.
    Sawaya, Raymond
    Weinberg, Jeffrey
    Prabhu, Sujit
    Fuller, Gregory
    Aldape, Kenneth
    Fueyo, Juan
    NEURO-ONCOLOGY, 2014, 16
1